As FOXM1 was overexpressed in BMDCs from TBM, we hypothesized H3K79me2‐FOXM1 regulated innate immune cells in pancreatic cancer and colon cancer. This evidence concerns the gene FOXM1 and familial pancreatic carcinoma.